img

Global Cervical Cancer Diagnostic Tests Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Cervical Cancer Diagnostic Tests Market Research Report 2024

Cervical cancer is a cancer arising from the cervix. It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body.
According to MRAResearch’s new survey, global Cervical Cancer Diagnostic Tests market is projected to reach US$ 9593 million in 2033, increasing from US$ 6855.4 million in 2022, with the CAGR of 4.5% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cervical Cancer Diagnostic Tests market research.
Key companies engaged in the Cervical Cancer Diagnostic Tests industry include QIAGEN, Hologic, Roche, Becton Dickinson, Quest Diagnostic and Abbott Pathology, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cervical Cancer Diagnostic Tests were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cervical Cancer Diagnostic Tests market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cervical Cancer Diagnostic Tests market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


QIAGEN
Hologic
Roche
Becton Dickinson
Quest Diagnostic
Abbott Pathology
Segment by Type
Pap Smear Tests
Colposcopy
HPV Testing
Endocervical Curettage (ECC)
Cone Biopsy
Others

Segment by Application


Hospitals
Ambulatory surgical centers
Specialty clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cervical Cancer Diagnostic Tests report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cervical Cancer Diagnostic Tests Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Pap Smear Tests
1.2.3 Colposcopy
1.2.4 HPV Testing
1.2.5 Endocervical Curettage (ECC)
1.2.6 Cone Biopsy
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cervical Cancer Diagnostic Tests Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Ambulatory surgical centers
1.3.4 Specialty clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cervical Cancer Diagnostic Tests Market Perspective (2018-2033)
2.2 Cervical Cancer Diagnostic Tests Growth Trends by Region
2.2.1 Global Cervical Cancer Diagnostic Tests Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cervical Cancer Diagnostic Tests Historic Market Size by Region (2018-2023)
2.2.3 Cervical Cancer Diagnostic Tests Forecasted Market Size by Region (2024-2033)
2.3 Cervical Cancer Diagnostic Tests Market Dynamics
2.3.1 Cervical Cancer Diagnostic Tests Industry Trends
2.3.2 Cervical Cancer Diagnostic Tests Market Drivers
2.3.3 Cervical Cancer Diagnostic Tests Market Challenges
2.3.4 Cervical Cancer Diagnostic Tests Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cervical Cancer Diagnostic Tests Players by Revenue
3.1.1 Global Top Cervical Cancer Diagnostic Tests Players by Revenue (2018-2023)
3.1.2 Global Cervical Cancer Diagnostic Tests Revenue Market Share by Players (2018-2023)
3.2 Global Cervical Cancer Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cervical Cancer Diagnostic Tests Revenue
3.4 Global Cervical Cancer Diagnostic Tests Market Concentration Ratio
3.4.1 Global Cervical Cancer Diagnostic Tests Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cervical Cancer Diagnostic Tests Revenue in 2022
3.5 Cervical Cancer Diagnostic Tests Key Players Head office and Area Served
3.6 Key Players Cervical Cancer Diagnostic Tests Product Solution and Service
3.7 Date of Enter into Cervical Cancer Diagnostic Tests Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cervical Cancer Diagnostic Tests Breakdown Data by Type
4.1 Global Cervical Cancer Diagnostic Tests Historic Market Size by Type (2018-2023)
4.2 Global Cervical Cancer Diagnostic Tests Forecasted Market Size by Type (2024-2033)
5 Cervical Cancer Diagnostic Tests Breakdown Data by Application
5.1 Global Cervical Cancer Diagnostic Tests Historic Market Size by Application (2018-2023)
5.2 Global Cervical Cancer Diagnostic Tests Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cervical Cancer Diagnostic Tests Market Size (2018-2033)
6.2 North America Cervical Cancer Diagnostic Tests Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cervical Cancer Diagnostic Tests Market Size by Country (2018-2023)
6.4 North America Cervical Cancer Diagnostic Tests Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cervical Cancer Diagnostic Tests Market Size (2018-2033)
7.2 Europe Cervical Cancer Diagnostic Tests Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cervical Cancer Diagnostic Tests Market Size by Country (2018-2023)
7.4 Europe Cervical Cancer Diagnostic Tests Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cervical Cancer Diagnostic Tests Market Size (2018-2033)
8.2 Asia-Pacific Cervical Cancer Diagnostic Tests Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cervical Cancer Diagnostic Tests Market Size by Region (2018-2023)
8.4 Asia-Pacific Cervical Cancer Diagnostic Tests Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cervical Cancer Diagnostic Tests Market Size (2018-2033)
9.2 Latin America Cervical Cancer Diagnostic Tests Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cervical Cancer Diagnostic Tests Market Size by Country (2018-2023)
9.4 Latin America Cervical Cancer Diagnostic Tests Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cervical Cancer Diagnostic Tests Market Size (2018-2033)
10.2 Middle East & Africa Cervical Cancer Diagnostic Tests Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cervical Cancer Diagnostic Tests Market Size by Country (2018-2023)
10.4 Middle East & Africa Cervical Cancer Diagnostic Tests Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 QIAGEN
11.1.1 QIAGEN Company Detail
11.1.2 QIAGEN Business Overview
11.1.3 QIAGEN Cervical Cancer Diagnostic Tests Introduction
11.1.4 QIAGEN Revenue in Cervical Cancer Diagnostic Tests Business (2018-2023)
11.1.5 QIAGEN Recent Development
11.2 Hologic
11.2.1 Hologic Company Detail
11.2.2 Hologic Business Overview
11.2.3 Hologic Cervical Cancer Diagnostic Tests Introduction
11.2.4 Hologic Revenue in Cervical Cancer Diagnostic Tests Business (2018-2023)
11.2.5 Hologic Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Cervical Cancer Diagnostic Tests Introduction
11.3.4 Roche Revenue in Cervical Cancer Diagnostic Tests Business (2018-2023)
11.3.5 Roche Recent Development
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Detail
11.4.2 Becton Dickinson Business Overview
11.4.3 Becton Dickinson Cervical Cancer Diagnostic Tests Introduction
11.4.4 Becton Dickinson Revenue in Cervical Cancer Diagnostic Tests Business (2018-2023)
11.4.5 Becton Dickinson Recent Development
11.5 Quest Diagnostic
11.5.1 Quest Diagnostic Company Detail
11.5.2 Quest Diagnostic Business Overview
11.5.3 Quest Diagnostic Cervical Cancer Diagnostic Tests Introduction
11.5.4 Quest Diagnostic Revenue in Cervical Cancer Diagnostic Tests Business (2018-2023)
11.5.5 Quest Diagnostic Recent Development
11.6 Abbott Pathology
11.6.1 Abbott Pathology Company Detail
11.6.2 Abbott Pathology Business Overview
11.6.3 Abbott Pathology Cervical Cancer Diagnostic Tests Introduction
11.6.4 Abbott Pathology Revenue in Cervical Cancer Diagnostic Tests Business (2018-2023)
11.6.5 Abbott Pathology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cervical Cancer Diagnostic Tests Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Pap Smear Tests
Table 3. Key Players of Colposcopy
Table 4. Key Players of HPV Testing
Table 5. Key Players of Endocervical Curettage (ECC)
Table 6. Key Players of Cone Biopsy
Table 7. Key Players of Others
Table 8. Global Cervical Cancer Diagnostic Tests Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Cervical Cancer Diagnostic Tests Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Cervical Cancer Diagnostic Tests Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Cervical Cancer Diagnostic Tests Market Share by Region (2018-2023)
Table 12. Global Cervical Cancer Diagnostic Tests Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Cervical Cancer Diagnostic Tests Market Share by Region (2024-2033)
Table 14. Cervical Cancer Diagnostic Tests Market Trends
Table 15. Cervical Cancer Diagnostic Tests Market Drivers
Table 16. Cervical Cancer Diagnostic Tests Market Challenges
Table 17. Cervical Cancer Diagnostic Tests Market Restraints
Table 18. Global Cervical Cancer Diagnostic Tests Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Cervical Cancer Diagnostic Tests Market Share by Players (2018-2023)
Table 20. Global Top Cervical Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cervical Cancer Diagnostic Tests as of 2022)
Table 21. Ranking of Global Top Cervical Cancer Diagnostic Tests Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Cervical Cancer Diagnostic Tests Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cervical Cancer Diagnostic Tests Product Solution and Service
Table 25. Date of Enter into Cervical Cancer Diagnostic Tests Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cervical Cancer Diagnostic Tests Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Cervical Cancer Diagnostic Tests Revenue Market Share by Type (2018-2023)
Table 29. Global Cervical Cancer Diagnostic Tests Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Cervical Cancer Diagnostic Tests Revenue Market Share by Type (2024-2033)
Table 31. Global Cervical Cancer Diagnostic Tests Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Cervical Cancer Diagnostic Tests Revenue Market Share by Application (2018-2023)
Table 33. Global Cervical Cancer Diagnostic Tests Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Cervical Cancer Diagnostic Tests Revenue Market Share by Application (2024-2033)
Table 35. North America Cervical Cancer Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Cervical Cancer Diagnostic Tests Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Cervical Cancer Diagnostic Tests Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Cervical Cancer Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Cervical Cancer Diagnostic Tests Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Cervical Cancer Diagnostic Tests Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Cervical Cancer Diagnostic Tests Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Cervical Cancer Diagnostic Tests Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Cervical Cancer Diagnostic Tests Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Cervical Cancer Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Cervical Cancer Diagnostic Tests Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Cervical Cancer Diagnostic Tests Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Cervical Cancer Diagnostic Tests Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Cervical Cancer Diagnostic Tests Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Cervical Cancer Diagnostic Tests Market Size by Country (2024-2033) & (US$ Million)
Table 50. QIAGEN Company Detail
Table 51. QIAGEN Business Overview
Table 52. QIAGEN Cervical Cancer Diagnostic Tests Product
Table 53. QIAGEN Revenue in Cervical Cancer Diagnostic Tests Business (2018-2023) & (US$ Million)
Table 54. QIAGEN Recent Development
Table 55. Hologic Company Detail
Table 56. Hologic Business Overview
Table 57. Hologic Cervical Cancer Diagnostic Tests Product
Table 58. Hologic Revenue in Cervical Cancer Diagnostic Tests Business (2018-2023) & (US$ Million)
Table 59. Hologic Recent Development
Table 60. Roche Company Detail
Table 61. Roche Business Overview
Table 62. Roche Cervical Cancer Diagnostic Tests Product
Table 63. Roche Revenue in Cervical Cancer Diagnostic Tests Business (2018-2023) & (US$ Million)
Table 64. Roche Recent Development
Table 65. Becton Dickinson Company Detail
Table 66. Becton Dickinson Business Overview
Table 67. Becton Dickinson Cervical Cancer Diagnostic Tests Product
Table 68. Becton Dickinson Revenue in Cervical Cancer Diagnostic Tests Business (2018-2023) & (US$ Million)
Table 69. Becton Dickinson Recent Development
Table 70. Quest Diagnostic Company Detail
Table 71. Quest Diagnostic Business Overview
Table 72. Quest Diagnostic Cervical Cancer Diagnostic Tests Product
Table 73. Quest Diagnostic Revenue in Cervical Cancer Diagnostic Tests Business (2018-2023) & (US$ Million)
Table 74. Quest Diagnostic Recent Development
Table 75. Abbott Pathology Company Detail
Table 76. Abbott Pathology Business Overview
Table 77. Abbott Pathology Cervical Cancer Diagnostic Tests Product
Table 78. Abbott Pathology Revenue in Cervical Cancer Diagnostic Tests Business (2018-2023) & (US$ Million)
Table 79. Abbott Pathology Recent Development
Table 80. Research Programs/Design for This Report
Table 81. Key Data Information from Secondary Sources
Table 82. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cervical Cancer Diagnostic Tests Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cervical Cancer Diagnostic Tests Market Share by Type: 2022 VS 2033
Figure 3. Pap Smear Tests Features
Figure 4. Colposcopy Features
Figure 5. HPV Testing Features
Figure 6. Endocervical Curettage (ECC) Features
Figure 7. Cone Biopsy Features
Figure 8. Others Features
Figure 9. Global Cervical Cancer Diagnostic Tests Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Cervical Cancer Diagnostic Tests Market Share by Application: 2022 VS 2033
Figure 11. Hospitals Case Studies
Figure 12. Ambulatory surgical centers Case Studies
Figure 13. Specialty clinics Case Studies
Figure 14. Cervical Cancer Diagnostic Tests Report Years Considered
Figure 15. Global Cervical Cancer Diagnostic Tests Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Cervical Cancer Diagnostic Tests Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Cervical Cancer Diagnostic Tests Market Share by Region: 2022 VS 2033
Figure 18. Global Cervical Cancer Diagnostic Tests Market Share by Players in 2022
Figure 19. Global Top Cervical Cancer Diagnostic Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cervical Cancer Diagnostic Tests as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Cervical Cancer Diagnostic Tests Revenue in 2022
Figure 21. North America Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Cervical Cancer Diagnostic Tests Market Share by Country (2018-2033)
Figure 23. United States Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Cervical Cancer Diagnostic Tests Market Share by Country (2018-2033)
Figure 27. Germany Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Cervical Cancer Diagnostic Tests Market Share by Region (2018-2033)
Figure 35. China Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Cervical Cancer Diagnostic Tests Market Share by Country (2018-2033)
Figure 43. Mexico Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Cervical Cancer Diagnostic Tests Market Share by Country (2018-2033)
Figure 47. Turkey Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Cervical Cancer Diagnostic Tests Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. QIAGEN Revenue Growth Rate in Cervical Cancer Diagnostic Tests Business (2018-2023)
Figure 50. Hologic Revenue Growth Rate in Cervical Cancer Diagnostic Tests Business (2018-2023)
Figure 51. Roche Revenue Growth Rate in Cervical Cancer Diagnostic Tests Business (2018-2023)
Figure 52. Becton Dickinson Revenue Growth Rate in Cervical Cancer Diagnostic Tests Business (2018-2023)
Figure 53. Quest Diagnostic Revenue Growth Rate in Cervical Cancer Diagnostic Tests Business (2018-2023)
Figure 54. Abbott Pathology Revenue Growth Rate in Cervical Cancer Diagnostic Tests Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed